Biotech Mergers: Evaluating Risk, Reporting, and Integration of Growth Strategies : Gilead’s Acquisition of Immunomedics: Risk and a Growth Strategy . (2025). The Accounting Educators’ Journal, 33. https://www.aejournal.com/ojs/index.php/aej/article/view/1044